Chugai Pharmaceutical Company Ltd.

Other News To Note.
BIOWORLD Today; 11/4/2009; 1842 words; ...licensee, Shire Pharmaceuticals Group plc, of...chairman of the company's supervisory...Hoffmann-La Roche Ltd., of Basel...an international pharmaceutical and medical device company. The license involves...product sales. The companies plan to share clinical...spin-off from ...

Roche Licenses Rights To IL-15 Preclinical Program From Cardion.
BIOWORLD Today; 11/4/2009; 1470 words; ...J.-based company, an affiliate of the Swiss pharmaceutical giant F. Hoffmann-La Roche Ltd., acquired...Germany-based company is eligible...sales. The companies did not disclose...He said the company remains focused...called Tolerance Pharmaceuticals Inc. in 2001...it is sold ...

Amgen Paying Roche $137.5M For European Neupogen Rights.
BIOWORLD Today; 11/4/2009; 881 words; ...Japanese subsidiary and Chugai Pharmaceutical Co. Ltd., a Tokyo-based company that has a competing product...the Seattle-based company being acquired by Amgen...June. The two West Coast companies on Friday said they will...

Europe Approves Amgen's Pair: Aranesp, Neulasta In Oncology.
BIOWORLD Today; 11/4/2009; 1015 words; ...oncology products from Amgen Inc. The company's stock (NASDAQ:AMGN) closed Wednesday...upcoming merger of its Japanese subsidiary and Chugai Pharmaceutical Co. Ltd., a Tokyo-based company that has a competing product. Neulasta...

Positive Early Data Halting Herceptin Phase III Studies.
BIOWORLD Today; 11/3/2009; 1649 words; ...75.50 Calling the company a "very conservative...cancer data with the company's Avastin (bevacizumab...Japan by Tokyo-based Chugai Pharmaceutical Co. Ltd., and internationally...Hoffmann-La Roche Ltd., of Basel, Switzerland...